Replies to post #531327 on NorthWest Biotherapeutics Inc (NWBO)

[exwannabe]

“Report out” are Dr. Liau’s words, not NWBO’s.

True, but NWBO could always clarify what is going on.

Every dev stage bio knows of PRs that I know of ha no problem announcing what would be a major paper being accepted for publication by a journal.

I guess the rest do not understand journal embargo policies or "best practice".

[NotSure2]

Not they are not. They are ATL insider saying LL said this.

We have no info on what she allegedly said before or after that.



As for timeline:
- There is a "Pre MAA Submission" timeline to follow.
+
An MAA submission timeline to follow. (including stop clock)

They submitted their Pip plan in Feb 2022. Which mean they started working on "pre MAA submission package in" ~ Oct 2021. (make sense). Their goal was to submit MAA in Sep2022. So they might announce MAA submission with JA next. (hopefully). Then we know we are ~ 8-12 months away from aproval or refusal. Would be nice to have a look at JA before this time, so we have a better idea about pulling out or keep being invested.

See this link for timeline:
https://www.propharmagroup.com/blog/roadmap-to-authorization-using-science-to-prepare-a-maa/